UK Industry Urges Quick Adoption Of Accelerated Access Proposals As Brexit Clouds Gather

UK review proposes key changes to the way that new medicines and medical technologies are identified, developed and adopted for use in the National Health Service, including an Accelerated Access Partnership of stakeholders that will manage the accelerated pathway to patients, a new government unit to discuss commercial arrangements, and a “transformative designation” to flag up products of greatest interest.